Lung transplant study aims to predict treatment success faster
NCT ID NCT07434869
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study looks for early signs that a treatment called ECP is working in people who have had a lung transplant and developed chronic rejection (CLAD). Researchers will collect blood samples and, for some, lung MRI scans before, during, and after ECP therapy. The goal is to find markers that show if the treatment is helping, so doctors can adjust care sooner. This is an observation-only study — participants receive the same ECP their doctor already prescribed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLAD, BRONCHIOLITIS OBLITERANS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
The Ohio State University Wexner Medical Center
NOT_YET_RECRUITINGColumbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lung transplant patients followed for years to uncover Long-Term health secrets
- Inhaled cyclosporine aims to halt lung transplant rejection
- Light therapy study sheds light on immune changes in transplant complication
- New blood test aims to catch lung transplant problems early
- Blood test could spot lung transplant trouble early
- Inhaled cyclosporine shows promise for lung transplant rejection